CSRP3 Gene Cardiomyopathy dilated type 1M Genetic Test
At DNA Labs UAE, we offer the CSRP3 Gene Cardiomyopathy dilated type 1M Genetic Test. This specific genetic test uses next-generation sequencing (NGS) technology to analyze the CSRP3 gene for mutations associated with dilated cardiomyopathy (DCM).
Test Components
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Cardiovascular Pneumology Disorders
Doctor: Cardiologist
Test Department: Genetics
Pre Test Information
Prior to the CSRP3 Gene Cardiomyopathy dilated type 1M NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with CSRP3 Gene Cardiomyopathy dilated type 1M NGS Genetic DNA Test gene CSRP3.
Test Details
Cardiomyopathy refers to a group of diseases that affect the heart muscle, leading to abnormalities in its structure and function. Dilated cardiomyopathy is characterized by the enlargement and weakening of the heart chambers, which can result in heart failure.
The CSRP3 gene provides instructions for producing a protein called cysteine and glycine-rich protein 3. This protein is involved in the organization and function of muscle cells, including those in the heart. Mutations in the CSRP3 gene can disrupt the normal function of the protein, leading to the development of dilated cardiomyopathy.
The NGS genetic test for CSRP3 gene cardiomyopathy, dilated type 1M involves sequencing the DNA of an individual to identify any mutations or variations in the CSRP3 gene that may be associated with the development of dilated cardiomyopathy. This test can help in diagnosing individuals with the condition, as well as identifying individuals who may be at risk of developing the disease.
The test is typically performed using a blood sample or a saliva sample, which is then sent to a laboratory for analysis. The laboratory uses NGS technology to sequence the entire CSRP3 gene and identify any mutations or variations.
The results of the test can help healthcare professionals in determining the appropriate treatment and management strategies for individuals with CSRP3 gene cardiomyopathy, dilated type 1M.
Test Name | CSRP3 Gene Cardiomyopathy dilated type 1M Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cardiovascular Pneumology Disorders |
Doctor | Cardiologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for CSRP3 Gene Cardiomyopathy, dilated type 1M NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CSRP3 Gene Cardiomyopathy, dilated type 1M NGS Genetic DNA Test gene CSRP3 |
Test Details |
CSRP3 gene cardiomyopathy, dilated type 1M is a specific type of genetic test that uses next-generation sequencing (NGS) technology to analyze the CSRP3 gene for mutations associated with dilated cardiomyopathy (DCM). Cardiomyopathy refers to a group of diseases that affect the heart muscle, leading to abnormalities in its structure and function. Dilated cardiomyopathy is characterized by the enlargement and weakening of the heart chambers, which can result in heart failure. The CSRP3 gene provides instructions for producing a protein called cysteine and glycine-rich protein 3. This protein is involved in the organization and function of muscle cells, including those in the heart. Mutations in the CSRP3 gene can disrupt the normal function of the protein, leading to the development of dilated cardiomyopathy. The NGS genetic test for CSRP3 gene cardiomyopathy, dilated type 1M involves sequencing the DNA of an individual to identify any mutations or variations in the CSRP3 gene that may be associated with the development of dilated cardiomyopathy. This test can help in diagnosing individuals with the condition, as well as identifying individuals who may be at risk of developing the disease. The test is typically performed using a blood sample or a saliva sample, which is then sent to a laboratory for analysis. The laboratory uses NGS technology to sequence the entire CSRP3 gene and identify any mutations or variations. The results of the test can help healthcare professionals in determining the appropriate treatment and management strategies for individuals with CSRP3 gene cardiomyopathy, dilated type 1M. |